We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App




New Version of 3-Part Differential Hematology Analyzer Launched

By LabMedica International staff writers
Posted on 08 Apr 2014
A new hematology analyzer is particularly suitable for small laboratories, satellite clinics, and doctors’ offices.

Launched by the Diatron Group (Budapest, Hungary) the new Abacus 3CT hematology analyzer is a compact, bench-top, flexible 3-part differential analyzer. More...
It offers 22 parameters thus delivering more patient data, and has a cap piercing capability that enables it to be used with sample tubes that are open or closed.

The new analyzer has been enhanced significantly from the original version. The most visually apparent changes are the introduction of the latest 8” high resolution and the color touch screen with new intuitive multilingual user interface, which makes it clear and simple to operate.

The new Abacus 3CT has an enhanced package of on-board quality control (QC) features. The QC capacity has been greatly increased to 24 lots, and QC values can now be loaded via QR codes or USB to avoid any incorrect assignment of values. Operating rights can also be assigned to selected operators to ensure that only trained persons can use the system. In addition, an on-board log details when reagents were last changed, with a constant on-screen display of reagent expiry dates as well as remaining reagent volumes. Other QC features include aperture anticlog protection and automatic cleaning after every 15 sample measurements.

To accommodate the increased volume of data generated by the 22 parameter measurements, the on-board data storage capacity of the Abacus 3CT has been doubled to 10,000 records, with improved laboratory information system (LIS) connectivity for results transfer.

Diatron develops, manufactures, and markets hematology and clinical chemistry analyzers, and associated reagents for human medical and veterinary use. An R&D/engineering team develops and manufactures a broad product range of products including: hematology analyzers, hematology reagents (both for its own and other manufacturers’ analyzers), hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.

Related Links:

Diatron Group



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.